chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: woke up feeling dizzy, like I had vertigo; woke up feeling dizzy, like I had vertigo; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old male patient received bnt162b2 (BNT162B2), administration date 23Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "not recovered", VERTIGO (non-serious), outcome "unknown" and all described as "woke up feeling dizzy, like I had vertigo". The event "woke up feeling dizzy, like i had vertigo" and "woke up feeling dizzy, like i had vertigo" was evaluated at the physician office visit. Therapeutic measures were taken as a result of dizziness, vertigo.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fall, Pain
Clinical narrative: fell; in pain; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team. The reporter is the patient. An elderly male patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunization. Relevant medical history included: "several back surgeries" (unspecified if ongoing); "doesn't drink" (ongoing); "smoke" (ongoing), notes: had stopped for a few weeks. Past drug history included: Morphine. The patient's concomitant medications were not reported. The following information was reported: FALL (non-serious), outcome "unknown", described as "fell"; PAIN (non-serious), outcome "unknown", described as "in pain".Therapeutic measures were taken as a result of pain. Additional information: After the first dose, the patient (Age: 68, Unit: Unknown) fell and was in pain and began smoking again.  He has a medical marijuana card and took one hit.  He also had old morphine from previously and the nurse told him it would be okay to take that.  After the second dose of the vaccine on unknown date, he began to take MOBIC  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Rapid-onset severe diarrhea within four hours of second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 07:30 (Batch/Lot number: unknown) at the age of 48 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Major depression" (unspecified if ongoing); "known allergies: Dairy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 Immunisation. The following information was reported: DIARRHOEA (non-serious) with onset 25Mar2021 11:00, outcome "recovering", described as "Rapid-onset severe diarrhea within four hours of second dose". Therapeutic measures were not taken as a result of diarrhoea.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Skin disorder
Clinical narrative: she has a bump on the hand that she received the vaccine; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 48 year-old female patient received bnt162b2 (BNT162B2), administration date 20Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SKIN DISORDER (non-serious) with onset 2021, outcome "unknown", described as "she has a bump on the hand that she received the vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP (patient), for a Pfizer sponsored program (159558). A 66-year-old female patient received the 2nd dose of BNT162B2 (Comirnaty, batch/lot# unknown), on Mar 26, 2021, single dose, for COVID-19 immunisation. Medical history included cancer (unspecified if ongoing) and cardiac ablation (unspecified if ongoing). The patient's concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Comirnaty), on Mar 4, 2021, for COVID-19 immunisation (reaction/s: tiredness, leg ache and diarrhea. Patient had a flu shot in 2019; and experienced reaction(s): whole arm started hurting down to my wrist. The patient reported pain in extremity/leg ache, with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "bone cancer" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness in arm where vaccine was injected; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Mar2021 14:30 (Lot number: 3248) at the age of 36 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. No COVID prior to vaccination. No other vaccine in four weeks. Vaccination history included: Bnt162b2 (dose number=1, product=COVID 19, brand=Pfizer, lot number=EL3248, vaccine location=Left arm), administration date: 03Mar2021, for COVID-19 IMMUNISATION. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 23Mar2021 22:00, outcome "recovered" (2021), described as "soreness in arm where vaccine was injected". Therapeutic measures were not taken as a result of vaccination site pain. Additional information: Facility type vaccine was at a workplace clinic. COVID was not tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Exhaustion; Upper arm soreness; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 36-year-old female patient received BNT162B2 (BNT162B2), administered in arm left, administration date 23Mar2021 11:45 (Lot number: EN6203) at the age of 36 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergies to sulfa" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Ceclor, reaction(s): "Allergies". Vaccination history included: Bnt162b2 (DOSE 1; Lot Number: EN6203; 11:45 AM; left arm), administration date: 01Mar2021, when the patient was 36 years old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 23Mar2021 14:00, outcome "recovering", described as "Exhaustion"; PAIN IN EXTREMITY (non-serious) with onset 23Mar2021 14:00, outcome "recovering", described as "Upper arm soreness". Therapeutic measures were not taken as a result of fatigue, pain in extremity.  Additional Information: The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The most recent vaccine was administered in a workplace clinic facility. Exhaustion was also reported to be administered within 2 hours of the vaccine. The patient has not been tested for COVID-19 post vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: just made me really tired; I had aches and pains afterwards for a day or two/whole body was sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 43-year-old patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "PTSD" (unspecified if ongoing); "real bad anxiety problems" (unspecified if ongoing); "panic attack" (unspecified if ongoing), notes: Patient is brought to the ER every time when having a bad panic attack. The patient's concomitant medications were not reported. Past drug history included: Xanax for PTSD, reaction(s): "did not have side effects"; Xanax for anxiety, reaction(s): "did not have side effects"; Chantix, reaction(s): "really vivid dreams about batman". The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "just made me really tired"; PAIN (non-serious), outcome "recovered", described as "I had aches and pains afterwards for a day or two/whole body was sore ".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Vaccination site rash
Clinical narrative: enlarged and painful lymph node; enlarged and painful lymph node; rash on right arm in the area of the shot; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), administered in arm right (Batch/Lot number: unknown) for 1 day as 2nd dose, single dose for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious), outcome "unknown" and all described as "enlarged and painful lymph node"; VACCINATION SITE RASH (non-serious), outcome "unknown", described as "rash on right arm in the area of the shot". Description of Event: 24 hours after the second Pfizer Covid-19 vaccine, patient experienced enlarged and painful lymph node under right armpit which was the same arm the vaccine was given. Patient also noted rash on right arm in the area of the shot.  No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 23Mar2021 14:00 (Lot number: EN6198) at the age of 77 years as dose 2, single for Covid-19 immunisation. Relevant medical history included: "tendonitis" (unspecified if ongoing), notes: she is taking a lot of natural vitamins for tendonitis and asthma; "asthma" (unspecified if ongoing), notes: she is taking a lot of natural vitamins for tendonitis and asthma. The patient took concomitant medications. Vaccination history included: BNT162B2 (Dose 1, Single, Batch/lot number: EN6207, Time: 14:00PM, Site: Left Arm), administration date: 02Mar2021, when the patient was 77 years old, for Covid-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 24Mar2021, outcome "recovered" (25Mar2021), described as "little tired last night". Additional Information: The patient got the shot 23Mar2021 and was taking a lot of natural vitamins for tendonitis and asthma. She asked if that will affect the vaccine. She said the vaccine was very good and was well accepted on her body. She mentioned she was a little tired last night but it was midnight and she felt recovered today. She clarified she had the first dose of the Pfizer COVID 19 vaccine on 02Mar2021 at 14:00PM in the left arm; and the second dose on 23Mar2021 at 14:00PM in the left arm. The patient has no history of all previous immunization and has no additional vaccines administered on same date of the COVID-19 Vaccine. The event did not require emergency room or physician office visit. The patient has no prior vaccinations within 4 weeks and has no family history and relevant tests. No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: experienced arm pain after first vaccination; This is a spontaneous report received from contactable reporter (Consumer) from a sales representative. The reporter is the patient.  A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "experienced arm pain after first vaccination". Additional Information: The patient was reported to be approximately 180lbs.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: This is a spontaneous report received from a consumer or other non-HCP (patient). A 46-year-old male patient received unknown dose number of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient had fatigue and headache, with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: headache; fatigue; body muscle aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) at the age of 43 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162B2 (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "headache"; FATIGUE (non-serious), outcome "recovered", described as "fatigue"; MYALGIA (non-serious), outcome "recovered", described as "body muscle aches". Therapeutic measures were taken as a result of headache, fatigue, myalgia. Additional information: Clinical course: Headache, fatigue, and body muscle aches, 24 hours after receiving second dose. Took paracetamol (TYLENOL) and events were resolved by 10 PM that same night.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Ophthalmological examination, Visual acuity reduced, Visual impairment, Vitreous floaters
Clinical narrative: Floaters in eye; he still has obstruction in his vision; he had a black dot in his vision that changed to more like a hair over the next day or two; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Mar2021 (Lot number: EN6207) at the age of 66 years as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VITREOUS FLOATERS (non-serious) with onset 12Mar2021, outcome "not recovered", described as "Floaters in eye"; VISUAL ACUITY REDUCED (non-serious) with onset 12Mar2021, outcome "not recovered", described as "he still has obstruction in his vision"; VISUAL IMPAIRMENT (non-serious) with onset 12Mar2021, outcome "not recovered", described as "he had a black dot in his vision that changed to more like a hair over the next day or two". The events "floaters in eye", "he still has obstruction in his vision" and "he had a black dot in his vision that changed to more like a hair over the next day or two" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vitreous floaters, visual acuity reduced, visual impairment. Additional information: The patient saw an eye doctor and stated that he has done no treatment. The eye clinic said that there is no treatment for the patient.    No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure before pregnancy
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP. A pregnant female patient received the 1st dose of BNT162B2 (Comirnaty, batch/lot# unknown), Mar 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Maternal exposure before pregnancy (patient got the first vaccine last week and found out she is pregnant) onset Mar 2021, with outcome unknown. The patient is expected to deliver baby(s) on Dec 30, 2021. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms after 2nd COVID vaccination; This is a spontaneous report received from a contactable consumer via a Pfizer colleague. The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu-like symptoms after 2nd COVID vaccination".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Malaise, Pain
Clinical narrative: not feeling good; Can't sleep; A little achy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 24Mar2021 10:30 (Lot number: EP6955) at the age of 73 years as dose 2, single for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Left arm, Administration time: approximately 10:30), administration date: 03Mar2021, when the patient was 73 years old, for Covid-19 immunization. The following information was reported: MALAISE (non-serious) with onset 25Mar2021, outcome "recovering", described as "not feeling good"; INSOMNIA (non-serious) with onset 25Mar2021, outcome "recovering", described as "Can't sleep"; PAIN (non-serious) with onset 25Mar2021, outcome "recovering", described as "A little achy".  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: I am still kind of bad/ Not feeling good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (First dose), for COVID-19 immunisation. The following information was reported: MALAISE (non-serious) with onset Mar2021, outcome "not recovered", described as "I am still kind of bad/ Not feeling good".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pain in extremity
Clinical narrative: sore arm; Sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "Sweating".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Arm is sore; mild aches all over body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 12:45 (Lot number: EP6955) at the age of 44 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ATORVASTATIN. Vaccination history included: Covid-19 vaccine (product=COVID 19, brand=Pfizer,, Lot number=EL3248,, Lot unknown=False,, Administration date=03Mar2021,, Vaccine location=Left arm,, Dose number=1), administration date: 03Mar2021, for Covid-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 25Mar2021, outcome "not recovered", described as "Arm is sore"; PAIN (non-serious) with onset 25Mar2021, outcome "not recovered", described as "mild aches all over body". Therapeutic measures were not taken as a result of pain in extremity, pain. Additional information: Patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received atorvastatin within 2 weeks of vaccination. No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain
Clinical narrative: woke up with pain and a bump under her armpit but not on her arm; woke up with pain and a bump under her armpit but not on her arm; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 23Mar2021 (Batch/Lot number: unknown) at the age of 42 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: COVID-19 vaccine (dose 1, Batch/Lot number: unknown), for COVID-19 immunisation. The following information was reported: AXILLARY PAIN (non-serious), AXILLARY MASS (non-serious) all with onset 25Mar2021, outcome "unknown" and all described as "woke up with pain and a bump under her armpit but not on her arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: wife only had some body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "wife only had some body aches".   Additional information: The reporter (patient's husband) only mentioned that the patient only had some body aches.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site soreness (arm) during the evening, for a first dose shot received that morning.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 62 year-old male patient received bnt162b2 (BNT162B2), administered in arm, administration date 23Mar2021 (Lot number: Unknown) at the age of 62 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Enlarged walls of heart" (unspecified if ongoing); "Lactose intolerance" (unspecified if ongoing). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 23Mar2021, outcome "recovered" (Mar2021), described as "Injection site soreness (arm) during the evening, for a first dose shot received that morning.". It was unknown if therapeutic measures were taken as a result of vaccination site pain. Additional information: Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: None at all issues with first dose, very mild soreness and that was it; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 01Mar2021 12:45 (Batch/Lot number: unknown) at the age of 26 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "vitamin d deficiency" (ongoing). Concomitant medication(s) included: VITAMIN D2 taken for vitamin d deficiency, start date: 2019 (ongoing). The following information was reported: PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "None at all issues with first dose, very mild soreness and that was it".  Additional information: The patient had no relevant family medical history. The patient had no prior vaccinations within 4 weeks. The patient did not receive additional vaccines administered on same date of the Pfizer suspect. The event did not result to emergency/physician office visit.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A female patient received the 1st dose of BNT162B2 (Comirnaty, batch/lot# unknown), on Feb 20, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient developed pain in extremity (her arm got sore), with outcome of recovered. Therapeutic measures were taken as a result of pain in extremity. Additional information: The patient stated with the first shot, her arm just got sore. She rubbed some alcohol on it and was alright. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Gastroenteritis viral
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP (patient), for a Pfizer sponsored program (159558). A female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient developed viral gastroenteritis/stomach virus. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: extreme fatigue; headache; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "extreme fatigue"; HEADACHE (non-serious) with onset Mar2021, outcome "unknown", described as "headache"; CHILLS (non-serious) with onset Mar2021, outcome "unknown", described as "chills".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: bad fatigue; chills; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "bad fatigue"; CHILLS (non-serious), outcome "unknown", described as "chills". Additional information: Patient had bad fatigue and was in bed because the chills doesn't go away.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness since day after the first dose with Pfizer (Covid vaccine); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old patient received bnt162b2 (BNT162B2), administration date 13Mar2021 (Lot number: EN6204) as dose 1, single for covid-19 immunisation. Relevant medical history included: "vertigo" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 14Mar2021, outcome "unknown", described as "dizziness since day after the first dose with Pfizer (Covid vaccine) ". The event "dizziness since day after the first dose with pfizer (covid vaccine) " was evaluated at the physician office visit.  Additional information: Patient has had vertigo before the patient knew how vertigo feels like. Patient has been to the doctor specialist for that and was told that this was not vertigo. Patient wanted to know if (the patient) should get the second shot (due on 03Apr2021) or not because (the patient) has not been able to work due to the dizziness.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A female patient received BNT162B2 (BNT162B2), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset Mar2021, outcome "not recovered", described as "Pain".  Additional information: The patient's husband reported that he and his wife (patient) received the 1st dose on 24Mar2021 at noon. The patient was experiencing pain until at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Poor quality product administered, Product colour issue
Clinical narrative: She added that her arm felt the soreness when the hcp administered the pink vaccine (2nd dose) to her.; The color of the 1st dose of that was administered to her was white and the 2nd dose was pink.; The color of the 1st dose of that was administered to her was white and the 2nd dose was pink.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 79 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "She added that her arm felt the soreness when the hcp administered the pink vaccine (2nd dose) to her."; PRODUCT COLOUR ISSUE (non-serious), POOR QUALITY PRODUCT ADMINISTERED (non-serious), outcome "unknown" and all described as "The color of the 1st dose of that was administered to her was white and the 2nd dose was pink.". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: pain at the injection site; muscle aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "pain at the injection site"; MYALGIA (non-serious), outcome "unknown", described as "muscle aches". Additional information: It was asked if patient could take TYLENOL to relieve the pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Infection
Clinical narrative: infection/prescribed with an antibiotic; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFECTION (non-serious), outcome "unknown", described as "infection/prescribed with an antibiotic". Therapeutic measures were taken as a result of infection. Additional information: Patient got her first dose last 04Mar2021 and her next dose would be on 25Mar2021 and she was prescribed with an antibiotic. She is asking if she can take the second dose today.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: This is a spontaneous report received from contactable consumer or other non-HCP (patient). A 68-year-old female patient received the 1st dose of BNT162B2 (Comirnaty, batch/lot# EL3302), at the age of 68, intramuscularly, right arm, on Jan 22, 2021, at 10:00, single dose, for COVID-19 immunisation. The patient has no medical history or concomitant medications. The patient reported chills and headache (some chills with 1st dose during the night with a headache, went away after 24 hours), onset Jan 22, 2021, with outcome of recovered (Jan 23, 2021). No therapeutic measures taken as a result of chills and headache. Additional information: No prior vaccinations (within 4 weeks). No tests reported. No follow-up attempts possible. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: This is a spontaneous report received from a noncontactable consumer or other non-HCP (patient). A patient (no qualifiers provided) received the 1st dose of BNT162B2 (Comirnaty, batch/lot# unknown), administration date: 2021, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. The patient felt abnormal/felt bad, onset 2021, with outcome of unknown. Additional information: The patient was supposed to at 11:00 am (unspecified date) get the second vaccination, but the night prior felt very bad and wondered if they should not go in. It has been three weeks at the time of the report. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Discomfort, Influenza like illness
Clinical narrative: Flu-like symptoms; feeling uncomfortable; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 immunisation.  The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "Flu-like symptoms"; DISCOMFORT (non-serious), outcome "unknown", described as "feeling uncomfortable".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: This is a spontaneous report received from contactable consumer or other non-HCP. A 31-year-old male patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), for COVID-19 immunisation. The patient experienced pain/body aches, chills, fatigue/exhaustion, with outcome of recovered. The events lasted for exactly 24 hours. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: This is a spontaneous report received from a consumer or other non-HCP (patient). A 36-year-old female patient (not pregnant) received the 2nd dose of BNT162B2 (Comirnaty, batch/lot# EP6955), at the age of 36, in left arm, on Mar 25, 2021, at  12:30, single dose, for COVID-19 immunisation. Medical history included intracranial hypertension (unspecified if ongoing); and asthma (unspecified if ongoing). Concomitant medication(s) included: Acetazolamide and Zyrtec (cetirizine hydrochloride). Vaccination history included the 1st dose of BNT162B2 (Comirnaty), at the age of 36, in left arm, on Mar 2, 2021, single dose, for COVID-19 immunization. The patient experienced  pain in extremity/sore arm and mild fatigue, onset Mar 25, 2021, at 21:00, with outcome of recovering. No therapeutic measures taken as a result of pain in extremity or fatigue. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID-19  vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little sore arm; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm, administration date 27Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "little sore arm". Therapeutic measures were taken as a result of pain in extremity. Additional information: The patient reported that she and her husband both received the second dose (Batch/lot number: EN6202) on 20Mar2021. The first dose was little lower to the down on the arm. The first one they got was on 27Feb2021 which they had very little to know reaction. Her husband had nothing; she had a little sore arm, put ice on it that was the end of it, and it was not yet (as reported).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Dizzy; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizzy"; HEADACHE (non-serious), outcome "unknown", described as "Headache".  Additional information: The patient received the vaccine in the morning, then after, the patient got dizzy and had headache. The patient was asking if that was common.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at injection site.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 14:00 (Batch/Lot number: unknown) at the age of 44 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Mar2021, outcome "recovering", described as "soreness at injection site.". Therapeutic measures were not taken as a result of vaccination site pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: very fatigued; have a lot of pain in our left calf of our leg. Very sore to the touch.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm right, administration date 19Mar2021 13:45 (Batch/Lot number: unknown) at the age of 60 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "afib" (unspecified if ongoing). There were no concomitant medications.  The following information was reported: FATIGUE (non-serious) with onset 22Mar2021 12:00, outcome "not recovered", described as "very fatigued"; PAIN IN EXTREMITY (non-serious) with onset 22Mar2021 12:00, outcome "not recovered", described as "have a lot of pain in our left calf of our leg. Very sore to the touch.". Therapeutic measures were not taken as a result of fatigue, pain in extremity.  Additional information: The patient did not have any known allergies to food, medications, or other products. The patient did not receive any other medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. . The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021351718 Same reporter, product, and event; different patient
Sex: M
Vaccine: COVID19
Symptoms: Illness, Limb discomfort, Lymphadenopathy
Clinical narrative: started to bother him and his arm; lymph node under his left arm is was swollen; terribly sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Mar2021 (Lot number: EN6202) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (The first one we got was the 27Feb), administration date: 27Feb2021, for Covid-19 immunization. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "started to bother him and his arm"; LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovered", described as "lymph node under his left arm is was swollen"; ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "terribly sick". Therapeutic measures (Tylenol and it has gone down to medicines) were taken as a result of lymphadenopathy. No follow-up attempts are possible. No further information is expected.